VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

10603	Companies
225004	Keywords
153728	Articles
119069	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 11/06/2024 at 17:40, 1 year 7 months ago

VALBIOTIS to launch Valbiotis®PRO Metabolic Health (Totum•63) for the prevention of metabolic diseases on the French market in February-March 2025.
Valbiotis announces the launch of Valbiotis®PRO Metabolic Health (Totum•63) on the French market in February-March 2025, addressing metabolic diseases preventively

Valbiotis Prevention French Market Metabolic Health TOTUM•63
BRIEF

published on 11/05/2024 at 18:05, 1 year 7 months ago

Valbiotis approves share buyback program at General Meeting

Share Buyback Valbiotis General Assembly Food Supplements Resolutions Voted
BRIEF

published on 10/29/2024 at 17:45, 1 year 7 months ago

Valbiotis Reports H1 2024 Financial Results and Strategic Developments

Valbiotis Product Launch Strategic Roadmap Interim Financials Scientific Results
PRESS RELEASE

published on 10/29/2024 at 17:40, 1 year 7 months ago

VALBIOTIS publishes its interim financial statements
Valbiotis publishes interim financial statements for H1 2024 showing a cash position of €18.5M and confirming its commercial roadmap. Key events review the successful launch of Valbiotis@PRO Cholesterol

Cash Position Valbiotis Product Launch Interim Financial Statements Commercial Roadmap
BRIEF

published on 10/17/2024 at 17:45, 1 year 8 months ago

Valbiotis: Ordinary General Meeting of November 5, 2024

Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
BRIEF

published on 10/15/2024 at 17:45, 1 year 8 months ago

Valbiotis celebrates the success of the INSIGHT study on TOTUM•854

Valbiotis Clinical Study INSIGHT Hypertension TOTUM•854
PRESS RELEASE

published on 10/15/2024 at 17:40, 1 year 8 months ago

Valbiotis announces the major success of the INSIGHT clinical study on TOTUM•854
Valbiotis announces major success of INSIGHT clinical study on TOTUM 854, demonstrating efficacy in reducing systolic blood pressure in individuals with untreated mild hypertension. Validation of innovative plant-based active ingredients

Valbiotis Plant-based INSIGHT Clinical Study TOTUM 854 Systolic Blood Pressure
BRIEF

published on 10/09/2024 at 17:50, 1 year 8 months ago

Valbiotis: Information on voting rights and shares, September 2024

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossings
BRIEF

published on 10/09/2024 at 17:50, 1 year 8 months ago

Update on Valbiotis voting rights for September 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 09/12/2024 at 17:50, 1 year 9 months ago

VALBIOTIS: Monthly information on voting rights and shares in August 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis

Accesswire

Published on 06/20/2026 at 01:00, 1 hour 16 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 hours 16 minutes ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 21 hours 46 minutes ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 1 hour ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/19/2026 at 20:17, 5 hours 59 minutes ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 7 hours 15 minutes ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 7 hours 47 minutes ago

Designated Person Notification
Published on 06/19/2026 at 18:00, 8 hours 16 minutes ago

Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 16:30, 9 hours 46 minutes ago

Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada

Les Echos

Published on 06/19/2026 at 19:33, 6 hours 43 minutes ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 6 hours 52 minutes ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 1 day 8 hours ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day 8 hours ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 day 8 hours ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026

View all LES ECHOS COMFI WIRE